JP2013514329A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013514329A5 JP2013514329A5 JP2012543778A JP2012543778A JP2013514329A5 JP 2013514329 A5 JP2013514329 A5 JP 2013514329A5 JP 2012543778 A JP2012543778 A JP 2012543778A JP 2012543778 A JP2012543778 A JP 2012543778A JP 2013514329 A5 JP2013514329 A5 JP 2013514329A5
- Authority
- JP
- Japan
- Prior art keywords
- linker
- compound
- compound according
- alkyl
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000005647 linker group Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 239000000412 dendrimer Substances 0.000 claims 2
- 229920000736 dendritic polymer Polymers 0.000 claims 2
- 239000000032 diagnostic agent Substances 0.000 claims 2
- 229940039227 diagnostic agent Drugs 0.000 claims 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- 150000002634 lipophilic molecules Chemical class 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 229920005615 natural polymer Polymers 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000000816 peptidomimetic Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 229920000768 polyamine Polymers 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20093555 | 2009-12-18 | ||
| NO20093555A NO331773B1 (no) | 2009-12-18 | 2009-12-18 | Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR) |
| PCT/EP2010/070029 WO2011073371A1 (en) | 2009-12-18 | 2010-12-17 | Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013514329A JP2013514329A (ja) | 2013-04-25 |
| JP2013514329A5 true JP2013514329A5 (enExample) | 2014-02-06 |
| JP5879268B2 JP5879268B2 (ja) | 2016-03-08 |
Family
ID=43770529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012543778A Active JP5879268B2 (ja) | 2009-12-18 | 2010-12-17 | マンガンキレート並びに磁気共鳴イメージング（ｍｒｉ）における造影剤としての使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9486544B2 (enExample) |
| EP (1) | EP2512524B1 (enExample) |
| JP (1) | JP5879268B2 (enExample) |
| KR (1) | KR101860160B1 (enExample) |
| CN (1) | CN102639152B (enExample) |
| AU (1) | AU2010332760B2 (enExample) |
| BR (1) | BR112012013761A2 (enExample) |
| CA (1) | CA2781228A1 (enExample) |
| DK (1) | DK2512524T3 (enExample) |
| ES (1) | ES2606165T3 (enExample) |
| HR (1) | HRP20161627T1 (enExample) |
| HU (1) | HUE032152T2 (enExample) |
| LT (1) | LT2512524T (enExample) |
| MX (1) | MX2012007041A (enExample) |
| NO (1) | NO331773B1 (enExample) |
| PL (1) | PL2512524T3 (enExample) |
| PT (1) | PT2512524T (enExample) |
| RU (1) | RU2561718C2 (enExample) |
| WO (1) | WO2011073371A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20170874T4 (hr) | 2013-04-26 | 2022-09-02 | Guerbet | Formulacija kontrastnog medija i odgovarajući postupak dobivanja |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| US10494379B2 (en) | 2015-11-26 | 2019-12-03 | Debreceni Egyetem | 6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents |
| EP3380472A1 (en) | 2015-11-26 | 2018-10-03 | Debreceni Egyetem | New 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca- 1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents |
| EP3380473A1 (en) | 2015-11-26 | 2018-10-03 | Debreceni Egyetem | New 2, 1 l -diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based mri contrast agents and 52mn based pet contrast agents |
| GB201610738D0 (en) * | 2016-06-20 | 2016-08-03 | Ge Healthcare As | Chelate compounds |
| CN110035996B (zh) | 2016-11-28 | 2022-08-09 | 拜耳医药股份公司 | 用于磁共振成像的新型高弛豫性钆螯合物 |
| JP7258753B2 (ja) | 2016-12-21 | 2023-04-17 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Ｍｒｉイメージング剤として好適なテトラアザビシクロ大員環系マンガンキレート化合物 |
| US11110186B2 (en) | 2017-12-20 | 2021-09-07 | General Electric Company | Anionic chelate compounds |
| EP3883613A1 (en) | 2018-11-23 | 2021-09-29 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
| CN111233982B (zh) * | 2018-11-28 | 2023-03-03 | 深圳先进技术研究院 | 一种小分子蛋白质及其应用 |
| US20220315616A1 (en) | 2019-09-03 | 2022-10-06 | Ge Healthcare As | Manganese chelate isomers |
| CN114874214B (zh) * | 2022-05-31 | 2023-03-21 | 南京航空航天大学 | 可偶联巯基的双功能大环螯合剂衍生物及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU608759B2 (en) | 1986-08-04 | 1991-04-18 | Amersham Health Salutar Inc | NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes |
| DE3640708C2 (de) | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
| US5334371A (en) * | 1988-07-20 | 1994-08-02 | Schering Aktiengesellschaft | Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI |
| NZ230778A (en) | 1988-09-27 | 1993-01-27 | Salutar Inc | Diagnostic imaging contrast medium comprising biscarbamoyl derivatives |
| WO1994026313A1 (en) * | 1993-05-06 | 1994-11-24 | The Dow Chemical Company | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents |
| SG46598A1 (en) * | 1991-12-10 | 1998-02-20 | Dow Chemical Co | Bicycloazamacroyclophosphonic acid conjugates contrast agents and preparation |
| SG48889A1 (en) * | 1991-12-10 | 1998-05-18 | Dow Chemical Co | Bicycle-polyamacrocyclocarboxylic acid complexes conjugates preparation and use as contrast agents |
| US5428139A (en) * | 1991-12-10 | 1995-06-27 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals |
| FR2836916B1 (fr) * | 2002-03-05 | 2004-06-11 | Guerbet Sa | Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese |
| FR2856689A1 (fr) * | 2003-06-25 | 2004-12-31 | Guerbet Sa | Composes specifiques a forte relaxivite |
| WO2006080022A2 (en) | 2005-01-31 | 2006-08-03 | Yeda Research And Development Co. Ltd. | Mri contrast agents for diagnosis and prognosis of tumors |
-
2009
- 2009-12-18 NO NO20093555A patent/NO331773B1/no unknown
-
2010
- 2010-12-17 EP EP10805224.2A patent/EP2512524B1/en active Active
- 2010-12-17 PT PT108052242T patent/PT2512524T/pt unknown
- 2010-12-17 RU RU2012124266/04A patent/RU2561718C2/ru not_active IP Right Cessation
- 2010-12-17 MX MX2012007041A patent/MX2012007041A/es not_active Application Discontinuation
- 2010-12-17 WO PCT/EP2010/070029 patent/WO2011073371A1/en not_active Ceased
- 2010-12-17 AU AU2010332760A patent/AU2010332760B2/en not_active Ceased
- 2010-12-17 CN CN201080056567.0A patent/CN102639152B/zh active Active
- 2010-12-17 CA CA2781228A patent/CA2781228A1/en not_active Abandoned
- 2010-12-17 LT LTEP10805224.2T patent/LT2512524T/lt unknown
- 2010-12-17 KR KR1020127015488A patent/KR101860160B1/ko not_active Expired - Fee Related
- 2010-12-17 JP JP2012543778A patent/JP5879268B2/ja active Active
- 2010-12-17 ES ES10805224.2T patent/ES2606165T3/es active Active
- 2010-12-17 HR HRP20161627TT patent/HRP20161627T1/hr unknown
- 2010-12-17 BR BR112012013761A patent/BR112012013761A2/pt not_active Application Discontinuation
- 2010-12-17 DK DK10805224.2T patent/DK2512524T3/en active
- 2010-12-17 US US13/510,064 patent/US9486544B2/en active Active
- 2010-12-17 HU HUE10805224A patent/HUE032152T2/en unknown
- 2010-12-17 PL PL10805224T patent/PL2512524T3/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013514329A5 (enExample) | ||
| RU2012124266A (ru) | Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb) | |
| JP2016153410A5 (enExample) | ||
| JP2012255007A5 (enExample) | ||
| JP2010527913A5 (enExample) | ||
| JP2013507423A5 (enExample) | ||
| JP2015512946A5 (enExample) | ||
| JP2013534248A5 (enExample) | ||
| RU2015149527A (ru) | Производные доластатина 10 и ауристатинов | |
| JP2011057686A5 (enExample) | ||
| JP2015509110A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| HRP20161577T1 (hr) | Inhibitori replikacije virusa gripe | |
| MX2010008468A (es) | Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante. | |
| JP2011528654A5 (enExample) | ||
| RU2014141545A (ru) | Нацеливающие аминокислотные липиды | |
| JP2013523896A5 (enExample) | ||
| JP2012515219A5 (enExample) | ||
| JP2008533007A5 (enExample) | ||
| HRP20110965T1 (hr) | Nove formulacije peptida povezanih s tumorima koji se vežu za molekule ljudskog leukocitnog antigena (hla) klase i ili ii za cjepiva | |
| JP2012521201A5 (enExample) | ||
| JP2012506896A5 (enExample) | ||
| JP2013523975A5 (enExample) | ||
| AR080491A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
| RU2016130448A (ru) | Пептидные дендримеры, содержащие фибриноген-связывающие пептиды |